<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00991575</url>
  </required_header>
  <id_info>
    <org_study_id>916501</org_study_id>
    <secondary_id>S-08843c/21262</secondary_id>
    <nct_id>NCT00991575</nct_id>
  </id_info>
  <brief_title>Long Term Vascular Changes in Type 1 Diabetes</brief_title>
  <acronym>DM09</acronym>
  <official_title>Long Term Vascular Changes in Type 1 Diabetes, Clinical Aspects and Biological Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Aker</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to investigate progression of late complications of
      diabetes during the last ten years in a well characterized cohort of type 1 diabetes with a
      long duration of the disease, and to define factors responsible for the progression of late
      complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite intensively research in the field of hyperglycaemia and coronary heart disease in
      type 1 diabetes it is still not known in detail how hyperglycaemia leads to damage of the
      vessels.

      The aims of the present proposal are therefore two-fold:

        1. To study in detail the progression of atherosclerosis (and micro vascular complications)
           in a well characterized cohort of type 1 diabetes with a long duration of the disease.
           This project will be a continuation of the Oslo study, a cohort started in 1982, with
           the last follow-up study in 1999/2000.

        2. To define factors responsible for the progression of coronary heart disease (and micro
           vascular complications) in this cohort.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fatal and non fatal cardiovascular disease (CVD) and stroke</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vessel area stenosis</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Complications</condition>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Diabetes, type 1</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, white cells, urine, tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This project will be a continuation of the previous cohort performed originally from 1982.
        The group or cohorts will be selected from primary care clinic.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        The original criteria from 1982:

        Inclusion Criteria:

          -  Age 18-45 years

          -  Diagnosis of type 1 diabetes at &lt; 30 years of age, disease duration &gt; 7 but &lt; 30 years

          -  C-peptide &lt; 0, 1 nmol/l

        Exclusion Criteria:

          -  Serum creatinine &gt; 150 Âµmol/l

          -  Diastolic blood pressure &lt;100mmHg

          -  Overt nephropathy

          -  Proliferative retinopathy

          -  Pregnancy

          -  A history of neuropathy

          -  Other chronical disease

          -  Treatment with other drugs except insulin and oral contraceptives
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristian F Hanssen, Professor MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo university hospital, Aker, Norway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo University hospital, Aker</name>
      <address>
        <city>Oslo</city>
        <zip>0514</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2009</study_first_submitted>
  <study_first_submitted_qc>October 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2009</study_first_posted>
  <last_update_submitted>October 7, 2009</last_update_submitted>
  <last_update_submitted_qc>October 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kristian F. Hanssen, Professor MD</name_title>
    <organization>Oslo University hospital</organization>
  </responsible_party>
  <keyword>Diabetes mellitus, type1</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>diabetes complications</keyword>
  <keyword>Glycation end products, advanced</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

